Accès gratuit
Numéro |
Med Sci (Paris)
Volume 29, Numéro 11, Novembre 2013
|
|
---|---|---|
Page(s) | 1018 - 1025 | |
Section | M/S Revues | |
DOI | https://doi.org/10.1051/medsci/20132911019 | |
Publié en ligne | 20 novembre 2013 |
- Fisher LW, Fedarko NS. Six genes expressed in bones and teeth encode the current members of the SIBLING family of proteins. Connect Tissue Res 2003 ; 44 : 33–40. [PubMed] [Google Scholar]
- Bellahcene A, Castronovo V, Ogbureke KU, et al. Small integrin-binding ligand N-linked glycoproteins (SIBLINGs) : multifunctional proteins in cancer. Nat Rev Cancer 2008 ; 8 : 212–226. [CrossRef] [PubMed] [Google Scholar]
- Staines KA, MacRae VE, Farquharson C. The importance of the SIBLING family of proteins on skeletal mineralisation and bone remodelling. J Endocrinol 2012 ; 214 : 241–255. [CrossRef] [PubMed] [Google Scholar]
- El-Tanani MK, Campbell FC, Kurisetty V, et al. The regulation and role of osteopontin in malignant transformation and cancer. Cytokine Growth Factor Rev 2006 ; 17 : 463–474. [CrossRef] [PubMed] [Google Scholar]
- Hanahan D, Weinberg RA. Hallmarks of cancer : the next generation. Cell 2011 ; 144 : 646–674. [CrossRef] [PubMed] [Google Scholar]
- Sung V, Stubbs JT, 3rd, Fisher L, et al. Bone sialoprotein supports breast cancer cell adhesion proliferation and migration through differential usage of the alpha(v)beta3 and alpha(v)beta5 integrins. J Cell Physiol 1998 ; 176 : 482–494. [CrossRef] [PubMed] [Google Scholar]
- Lee JL, Wang MJ, Sudhir PR, et al. Osteopontin promotes integrin activation through outside-in and inside-out mechanisms : OPN-CD44V interaction enhances survival in gastrointestinal cancer cells. Cancer Res 2007 ; 67 : 2089–2097. [CrossRef] [PubMed] [Google Scholar]
- Pecheur I, Peyruchaud O, Serre CM, et al. Integrin alpha(v)beta3 expression confers on tumor cells a greater propensity to metastasize to bone. Faseb J 2002 ; 16 : 1266–1268. [PubMed] [Google Scholar]
- von Marschall Z, Fisher LW. Dentin matrix protein-1 isoforms promote differential cell attachment and migration. J Biol Chem 2008 ; 283 : 32730–32740. [CrossRef] [PubMed] [Google Scholar]
- Khodavirdi AC, Song Z, Yang S, et al. Increased expression of osteopontin contributes to the progression of prostate cancer. Cancer Res 2006 ; 66 : 883–888. [CrossRef] [PubMed] [Google Scholar]
- Courter D, Cao H, Kwok S, et al. The RGD domain of human osteopontin promotes tumor growth and metastasis through activation of survival pathways. PLoS One 2010 ; 5 : e9633. [CrossRef] [PubMed] [Google Scholar]
- Ahmed M, Behera R, Chakraborty G, et al. Osteopontin : a potentially important therapeutic target in cancer. Expert Opin Ther Targets 2011 ; 15 : 1113–1126. [CrossRef] [PubMed] [Google Scholar]
- Kayed H, Kleeff J, Keleg S, et al. Effects of bone sialoprotein on pancreatic cancer cell growth, invasion and metastasis. Cancer Lett 2007 ; 245 : 171–183. [CrossRef] [PubMed] [Google Scholar]
- Joshi R, Tawfik A, Edeh N, et al. Dentin sialophosphoprotein (DSPP) gene-silencing inhibits key tumorigenic activities in human oral cancer cell line, OSC2. PLoS One 2010 ; 5 : e13974. [CrossRef] [PubMed] [Google Scholar]
- Rangaswami H, Kundu GC. Osteopontin stimulates melanoma growth and lung metastasis through NIK/MEKK1-dependent MMP-9 activation pathways. Oncol Rep 2007 ; 18 : 909–915. [PubMed] [Google Scholar]
- Khan SA, Cook AC, Kappil M, et al. Enhanced cell surface CD44 variant (v6, v9) expression by osteopontin in breast cancer epithelial cells facilitates tumor cell migration : novel post-transcriptional, post-translational regulation. Clin Exp Metastasis 2005 ; 22 : 663–673. [CrossRef] [PubMed] [Google Scholar]
- Irby RB, McCarthy SM, Yeatman TJ. Osteopontin regulates multiple functions contributing to human colon cancer development and progression. Clin Exp Metastasis 2004 ; 21 : 515–523. [CrossRef] [PubMed] [Google Scholar]
- Yan W, Qian C, Zhao P, et al. Expression pattern of osteopontin splice variants and its functions on cell apoptosis and invasion in glioma cells. Neuro Oncol 2010 ; 12 : 765–775. [CrossRef] [PubMed] [Google Scholar]
- Sharp JA, Waltham M, Williams ED, et al. Transfection of MDA-MB-231 human breast carcinoma cells with bone sialoprotein (BSP) stimulates migration and invasion in vitro and growth of primary and secondary tumors in nude mice. Clin Exp Metastasis 2004 ; 21 : 19–29. [CrossRef] [PubMed] [Google Scholar]
- Takafuji V, Forgues M, Unsworth E, et al. An osteopontin fragment is essential for tumor cell invasion in hepatocellular carcinoma. Oncogene 2007 ; 26 : 6361–6371. [CrossRef] [PubMed] [Google Scholar]
- Mangala LS, Arun B, Sahin AA, Mehta K. Tissue transglutaminase-induced alterations in extracellular matrix inhibit tumor invasion. Mol Cancer 2005 ; 4 : 33. [CrossRef] [PubMed] [Google Scholar]
- Fedarko NS, Jain A, Karadag A, Fisher LW. Three small integrin binding ligand N-linked glycoproteins (SIBLINGs) bind and activate specific matrix metalloproteinases. Faseb J 2004 ; 18 : 734–736. [PubMed] [Google Scholar]
- Fisher LW, Jain A, aTayback M, Fedarko NS. Small integrin binding ligand N-linked glycoprotein gene family expression in different cancers. Clin Cancer Res 2004 ; 10: 8501–8511. [CrossRef] [PubMed] [Google Scholar]
- Ogbureke KU, Nikitakis NG, Warburton G, et al. Up-regulation of SIBLING proteins and correlation with cognate MMP expression in oral cancer. Oral Oncol 2007 ; 43 : 920–932. [CrossRef] [PubMed] [Google Scholar]
- Karadag A, Ogbureke KU, Fedarko NS, Fisher LW. Bone sialoprotein, matrix metalloproteinase 2, and alpha(v)beta3 integrin in osteotropic cancer cell invasion. J Natl Cancer Inst 2004 ; 96 : 956–965. [CrossRef] [PubMed] [Google Scholar]
- Karadag A, Fedarko NS, Fisher LW. Dentin matrix protein 1 enhances invasion potential of colon cancer cells by bridging matrix metalloproteinase-9 to integrins and CD44. Cancer Res 2005 ; 65 : 11545–11552. [CrossRef] [PubMed] [Google Scholar]
- Fedarko NS, Fohr B, Robey PG, et al. Factor H binding to bone sialoprotein and osteopontin enables tumor cell evasion of complement-mediated attack. J Biol Chem 2000 ; 275 : 16666–16672. [CrossRef] [PubMed] [Google Scholar]
- Jain A, Karadag A, Fohr B, et al. Three SIBLINGs (small integrin-binding ligand, N-linked glycoproteins) enhance factor H’s cofactor activity enabling MCP-like cellular evasion of complement-mediated attack. J Biol Chem 2002 ; 277 : 13700–13708. [CrossRef] [PubMed] [Google Scholar]
- Fidler IJ. The pathogenesis of cancer metastasis : the ‘seed and soil’ hypothesis revisited. Nat Rev Cancer 2003 ; 3 : 453–458. [CrossRef] [PubMed] [Google Scholar]
- Wai PY, Kuo PC. Osteopontin : regulation in tumor metastasis. Cancer Metastasis Rev 2008 ; 27 : 103–118. [CrossRef] [PubMed] [Google Scholar]
- Oates AJ, Barraclough R, Rudland PS. The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model. Oncogene 1996 ; 13 : 97–104. [PubMed] [Google Scholar]
- Adwan H, Bauerle TJ, Berger MR. Downregulation of osteopontin and bone sialoprotein II is related to reduced colony formation and metastasis formation of MDA-MB-231 human breast cancer cells. Cancer Gene Ther 2004 ; 11 : 109–120. [CrossRef] [PubMed] [Google Scholar]
- Mandelin J, Lin EC, Hu DD, et al. Extracellular and intracellular mechanisms that mediate the metastatic activity of exogenous osteopontin. Cancer 2009 ; 115 : 1753–1764. [CrossRef] [PubMed] [Google Scholar]
- Bellahcene A, Merville MP, Castronovo V. Expression of bone sialoprotein, a bone matrix protein, in human breast cancer. Cancer Res 1994 ; 54 : 2823–2826. [PubMed] [Google Scholar]
- Waltregny D, Bellahcene A, Van Riet I, et al. Prognostic value of bone sialoprotein expression in clinically localized human prostate cancer. J Natl Cancer Inst 1998 ; 90 : 1000–1008. [CrossRef] [PubMed] [Google Scholar]
- Kang Y, Siegel PM, Shu W, et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 2003 ; 3 : 537–549. [CrossRef] [PubMed] [Google Scholar]
- Zhang JH, Tang J, Wang J, et al. Over-expression of bone sialoprotein enhances bone metastasis of human breast cancer cells in a mouse model. Int J Oncol 2003 ; 23 : 1043–1048. [PubMed] [Google Scholar]
- Zhang JH, Wang J, Tang J, et al. Bone sialoprotein promotes bone metastasis of a non-bone-seeking clone of human breast cancer cells. Anticancer Res 2004 ; 24 : 1361–1368. [PubMed] [Google Scholar]
- Koeneman KS, Yeung F, Chung LW. Osteomimetic properties of prostate cancer cells : a hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment. Prostate 1999 ; 39 : 246–261. [CrossRef] [PubMed] [Google Scholar]
- Bellahcene A, Bachelier R, Detry C, et al. Transcriptome analysis reveals an osteoblast-like phenotype for human osteotropic breast cancer cells. Breast Cancer Res Treat 2007 ; 101 : 135–148. [CrossRef] [PubMed] [Google Scholar]
- Barnes GL, Javed A, Waller SM, et al. Osteoblast-related transcription factors Runx2 (Cbfa1/AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells. Cancer Res 2003 ; 63 : 2631–2637. [PubMed] [Google Scholar]
- Brooks PC, Clark RA, Cheresh DA. Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 1994 ; 264 : 569–571. [CrossRef] [PubMed] [Google Scholar]
- Wang Y, Yan W, Lu X, et al. Overexpression of osteopontin induces angiogenesis of endothelial progenitor cells via the avbeta3/PI3K/AKT/eNOS/NO signaling pathway in glioma cells. Eur J Cell Biol 2011 ; 90 : 642–648. [CrossRef] [PubMed] [Google Scholar]
- Cui R, Takahashi F, Ohashi R, et al. Abrogation of the interaction between osteopontin and alphavbeta3 integrin reduces tumor growth of human lung cancer cells in mice. Lung Cancer 2007 ; 57 : 302–310. [CrossRef] [PubMed] [Google Scholar]
- Dai J, Peng L, Fan K, et al. Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells. Oncogene 2009 ; 28 : 3412–3422. [CrossRef] [PubMed] [Google Scholar]
- Blasberg JD, Goparaju CM, Pass HI, Donington JS. Lung cancer osteopontin isoforms exhibit angiogenic functional heterogeneity. J Thorac Cardiovasc Surg 2010 ; 139 : 1587–1593. [CrossRef] [PubMed] [Google Scholar]
- Bellahcene A, Bonjean K, Fohr B, et al. Bone sialoprotein mediates human endothelial cell attachment and migration and promotes angiogenesis. Circ Res 2000 ; 86 : 885–891. [CrossRef] [PubMed] [Google Scholar]
- Pirotte S, Lamour V, Lambert V, et al. Dentin matrix protein 1 induces membrane expression of VE-cadherin on endothelial cells and inhibits VEGF-induced angiogenesis by blocking VEGFR-2 phosphorylation. Blood 2011 ; 117 : 2515–2526. [CrossRef] [PubMed] [Google Scholar]
- Bucciarelli E, Sidoni A, Bellezza G, et al. Low dentin matrix protein 1 expression correlates with skeletal metastases development in breast cancer patients and enhances cell migratory capacity in vitro. Breast Cancer Res Treat 2007 ; 105 : 95–104. [CrossRef] [PubMed] [Google Scholar]
- Chabas D. L’ostéopontine, une molécule aux multiples facettes. Med Sci (Paris) 2005 ; 21 : 832–838. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Orian-Rousseau V. CD44, un régulateur de la croissance et de l’invasion cellulaire. Med Sci (Paris) 2003 ; 19 : 405–407. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Bidard FC, Poupon MF. Biologie du processus métastatique. Med Sci (Paris) 2012 ; 28 : 89–95. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.
Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.
Le chargement des statistiques peut être long.